WHO in talks with Russia on emergency use of Sputnik coronavirus vaccine
The World Health Organization (WHO) is in discussions with the Russian institute that developed the Sputnik V candidate vaccine against COVID-19 over its potential application for emergency use listing, the UN agency said on Thursday.
For more coronavirus news, visit our dedicated page.
In a statement to Reuters, the WHO said: “We look forward to receiving the data for their Sputnik V candidate vaccine. If a product submitted for assessment is found to meet the criteria for listing, WHO will publish the results widely.”
For all the latest headlines follow our Google News channel online or via the app
By granting the vaccine emergency use listing, the WHO would effectively be recommending its use to member states.
Russia’s Sputnik V vaccine is 92 percent effective at protecting people from COVID-19 according to interim trial results, the country’s sovereign wealth fund said on Wednesday.
Read more: After Pfizer’s vaccine announcement, Russia says it own vaccine over 90 pct effective
Also Read
-
Russia to sell 100 mln doses of COVID-19 vaccine Sputnik-V to India
Russia’s sovereign wealth fund has agreed to supply 100 million doses of its coronavirus vaccine, Sputnik-V, to Indian drug company Dr Reddy’s ... Coronavirus -
Coronavirus: Russia reports record daily high of COVID-19 deaths
Russia reported a record high of 439 new deaths linked to the novel coronavirus on Thursday and authorities in Moscow said they could consider ... Coronavirus -
Coronavirus: Russia to start trials for second COVID-19 vaccine shot
Post-registration trials of Russia’s second COVID-19 vaccine are expected to start on Sunday, Deputy Prime Minister Tatiana Golikova said, as ... Coronavirus -
Coronavirus: Chinese firm obtains right to develop Russia’s Sputnik V vaccine
Chinese firm Tibet Rhodiola Pharmaceutical Holding said on Wednesday it had obtained the non-exclusive rights to develop, manufacture, import or ... Coronavirus -
Russia says its Sputnik V coronavirus vaccine is 92 pct effective in interim results
Russia’s Sputnik V vaccine is 92 percent effective at protecting people from COVID-19 according to interim trial results, the country’s sovereign ... Coronavirus -
Coronavirus: Turkey interested in producing Russia’s Sputnik V vaccine
Turkey is interested in producing Russia’s first coronavirus vaccine, Sputnik V, at domestic facilities, Russia’s health ministry said on Wednesday ... Coronavirus -
After Pfizer’s vaccine announcement, Russia says it own vaccine over 90 pct effective
Russia’s Sputnik V vaccine against the coronavirus is more than 90 percent effective, a health ministry official said on Monday.The announcement came ... Coronavirus
